Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Sana Biotechnology, Inc. | 65,000 | reported | 06 Jun 2024 | tx 6+263,278−23,591 |
| Denali Therapeutics Inc. | 26,564 | reported | 01 Jun 2023 | tx 13+173,035−3,253 |
| Foghorn Therapeutics Inc. | 25,000 | reported | 17 Jun 2025 | tx 5+85,530 |
| AVEO PHARMACEUTICALS INC | 23,909 | reported | 16 May 2011 | tx 70+2,521,804−3,987,436 |
| TETRAPHASE PHARMACEUTICALS INC | 20,000 | reported | 25 Mar 2013 | tx 2+40,000 |
| Receptos, Inc. | 18,800 | reported | 17 Jul 2013 | tx 1+18,800 |
| Quanterix Corp | 7,900 | reported | 02 Jan 2019 | tx 4+20,340 |
| Editas Medicine, Inc. | 3,171 | reported | 17 Aug 2017 | tx 3+14,709 |
| AGIOS PHARMACEUTICALS, INC. | 2,778 | reported | 10 Aug 2016 | tx 5+33,903 |
| Sigilon Therapeutics, Inc. | 0 | reported | 11 Aug 2023 | tx 5+26,664−1,366 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Jun 2025 | GRANT_AWARD | Foghorn Therapeutics Inc. | 25,000 | 4.79 USD | deriv |
| 26 Jun 2024 | GRANT_AWARD | Foghorn Therapeutics Inc. | 16,000 | 5.52 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | Sana Biotechnology, Inc. | 54,278 | 0.00 USD | deriv |
| 11 Aug 2023 | OTHER | Sigilon Therapeutics, Inc. | 683 | 5.00 USD | deriv |
| 11 Aug 2023 | OTHER | Sigilon Therapeutics, Inc. | 683 | 6.64 USD | deriv |
| 21 Jun 2023 | GRANT_AWARD | Foghorn Therapeutics Inc. | 16,000 | 0.00 USD | deriv |
| 08 Jun 2023 | GRANT_AWARD | Sana Biotechnology, Inc. | 65,000 | 0.00 USD | deriv |
| 01 Jun 2023 | GRANT_AWARD | Denali Therapeutics Inc. | 4,216 | 0.00 USD | |
| 01 Jun 2023 | GRANT_AWARD | Denali Therapeutics Inc. | 12,649 | 0.00 USD | deriv |
| 19 May 2023 | GRANT_AWARD | Sigilon Therapeutics, Inc. | 8,888 | 0.00 USD | deriv |
| 21 Jun 2022 | GRANT_AWARD | Foghorn Therapeutics Inc. | 16,000 | 0.00 USD | deriv |
| 06 Jun 2022 | GRANT_AWARD | Sana Biotechnology, Inc. | 65,000 | 0.00 USD | deriv |
| 02 Jun 2022 | GRANT_AWARD | Denali Therapeutics Inc. | 5,986 | 0.00 USD | |
| 02 Jun 2022 | GRANT_AWARD | Denali Therapeutics Inc. | 17,959 | 0.00 USD | deriv |
| 26 May 2022 | GRANT_AWARD | Sigilon Therapeutics, Inc. | 8,888 | 0.00 USD | deriv |
| 13 Jul 2021 | GRANT_AWARD | Foghorn Therapeutics Inc. | 12,530 | 0.00 USD | deriv |
| 24 Jun 2021 | GRANT_AWARD | Sigilon Therapeutics, Inc. | 8,888 | 9.97 USD | deriv |
| 02 Jun 2021 | GRANT_AWARD | Denali Therapeutics Inc. | 2,074 | 0.00 USD | |
| 02 Jun 2021 | GRANT_AWARD | Denali Therapeutics Inc. | 6,222 | 0.00 USD | deriv |
| 01 Jun 2021 | EXERCISE | Denali Therapeutics Inc. | 3,253 | 0.00 USD | |
| 01 Jun 2021 | EXERCISE | Denali Therapeutics Inc. | 3,253 | 0.00 USD | deriv |
| 03 Feb 2021 | GRANT_AWARD | Sana Biotechnology, Inc. | 14,000 | 0.00 USD | deriv |
| 03 Jun 2020 | GRANT_AWARD | Denali Therapeutics Inc. | 3,253 | 0.00 USD | deriv |
| 03 Jun 2020 | GRANT_AWARD | Denali Therapeutics Inc. | 15,183 | 0.00 USD | deriv |
| 30 May 2019 | GRANT_AWARD | Denali Therapeutics Inc. | 27,245 | 0.00 USD | deriv |